1) Mary Ann Liebert. Metabolic syndrome and related disorders. Metabolic Syndrome. Volume 1, number 1, 2003
2) Meigs JB. Pre-metabolic Syndrome. BMJ 2003;327:61-62 (12 July)
3) Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998;15: 539-53.[CrossRef][ISI][Medline
4) Stagnaro S., Stagnaro-Neri M. Valutazione percusso-ascoltatoria del Diabete Mellito. Aspetti teorici e pratici. Epat. 32, 131, 1986.
5) Stagnaro S. Diet and Risk of Type 2 Diabetes. N Engl J Med. 2002 Jan 24;346(4):297-298. [PubMed indexed for Medline]
6) Stagnaro S. Pre-Metabolic Syndrome. Locus of Type 2 Diabetes Primary Prevention. 1 August 2003. http://bmj.com/cgi/eletters/327/7409/266#35204 .
7) Reaven G. Insulin resistance: Why is it important? What is the link between it and cardiovascular disease? How can you recognize it? Program of the American Association of Clinical Endocrinologists 12th Annual Meeting and Clinical Congress; May 14-18, 2003; San Diego, California
8) Reaven GM, Chen YD, Jeppesen J, Maheux P, Krauss RM. Insulin resistance and hyperinsulinemia in individuals with small, dense low density lipoprotein particles. J Clin Invest. 1993;92:141-146. Abstract
9) Abbasi F, McLaughlin T, Lamendola C, et al. Fasting remnant lipoprotein cholesterol and triglyceride concentrations are elevated in nondiabetic, insulin-resistant, female volunteers. J Clin Endocrinol Metab. 1999;84:3903-3906. Abstract
10) Chen NG, Abbasi F, Lamendola C, et al. Mononuclear cell adherence to cultured endothelium is enhanced by hypertension and insulin resistance in healthy nondiabetic volunteers. Circulation. 1999;100:940-943. Abstract 11) Stagnaro S., Stagnaro-Neri M., Basi microcircolatorie della semeiotica biofisica. Atti del XVII Cong. Naz. Soc. Ital. Studio Microcircolazione, Firenze ott. 1995, Biblioteca Scient. Scuola Sanità Militare, 1995, 2, 94.
12) Chen NG, Abbasi F, Lamendola C, et al. Mononuclear cell adherence to cultured endothelium is enhanced by hypertension and insulin resistance in healthy nondiabetic volunteers. Circulation. 1999;100:940-943. Abstract
13) Stuhlinger MC, Abbasi F, Chu JW, et al. Relationship between insulin resistance and an endogenous nitric oxide synthase inhibitor. JAMA. 2002;287:1420-1426. Abstract 14) Stagnaro S. “Biophysical-Semeiotic Constitutions: URL http://digilander.libero.it/semeioticabiofisica/constitutions.htm 
15) Stagnaro S., Istangiopatia Congenita Acidosica Enzimo-Metabolica condizione necessaria non sufficiente della oncogenesi. XI Congr. Naz. Soc. It. di Microangiologia e Microcircolaz. Abstracts, pg 38, 28 Settembre-1 Ottobre, Bellagio,1983
16) Stagnaro S., Istangiopatia Congenita Acidosica Enzimo-Metabolica. X Congr. Naz. Soc. It. di Microangiologia e Microcircolazione. Atti, 61. 6-7 Novembre, Siena,1981
17) Stagnaro S., Istangiopatia Congenita Acidosica Enzimo-Metabolica. Una Patologia Mitocondriale Ignorata. Gazz Med. It. – Arch. Sci. Med. 144, 423, 1985 (Infotrieve)
18) Stagnaro S., Diet and Risk of Type 2 Diabetes. N Engl J Med. 2002 Jan
24;346(4):297-298. letter [PubMed indexed for MEDLINE]. 19) Stagnaro S., Stagnaro-Neri M. Valutazione percusso-ascoltatoria del Diabete Mellito. Aspetti teorici e pratici. Epat. 32, 131
20) Stagnaro S. Diabetic Constitution, http://digilander.libero.it/semeioticabiofisica/Biography.htm 
21) Stagnaro S. Dyslipidemic Constitution, http://digilander.libero.it/semeioticabiofisica/Biography.htm 
22) Stagnaro S. Biophysical-semeiotic diagnosis of diabetes mellitus since its initial stages .

http://digilander.libero.it/semeioticabiofisica/Biography.htm
23) Stagnaro S. Biophysical-semeiotic evaluation of insular amyloid in bed-side diagnosing diabetes mellitus type ii, since initial stage.
http://digilander.libero.it/semeioticabiofisica/Biography.htm 
24) Stagnaro S. From Diabetic and Dyslipidemic Biophysical-Semeiotic Constitutions to Type 2 Diabetes Mellitus. http://digilander.libero.it/semeioticabiofisica/Biography.htm 
25) Stagnaro S. Beyond Hyperinsulinemia-Insulin Resistance in the War against Arteriosclerosis and type 2 Diabetes Mellitus.
http://digilander.libero.it/semeioticabiofisica/Biography.htm 
26) Stagnaro S. Diabetic constitution, obesity, insulin-resistance, ppars, and type 2 diabetes mellitus. http://digilander.libero.it/semeioticabiofisica/Biography.htm
27) Stagnaro S. Beyond glycemia: biophysical-semeiotic evaluation of glycemic metabolism. http://digilander.libero.it/semeioticabiofisica/Biography.htm
28) Stagnaro-Neri M., Stagnaro S., Deterministic Chaos, Preconditioning and Myocardial Oxygenation evaluated clinically with the aid of Biophysical Semeiotics in the Diagnosis of ischaemic Heart Disease even silent. Acta Med. Medit. 13, 109, 1997.
29) Stagnaro S. Biophysical-Semeiotic Preconditioning.
30) Stagnaro S. Malignancy and Mitochondrial Dysfunction. JCI, (10 February 2003) http://www.jci.org/cgi/eletters/111/3/303